Updated: January 17, 2026
Alternatives to Yupelri If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Why Is Yupelri Unique? (And Why Alternatives Aren't Always Identical)
- Other LAMA Medications (Same Drug Class as Yupelri)
- 1. Tiotropium (Spiriva HandiHaler / Spiriva Respimat)
- 2. Umeclidinium (Incruse Ellipta)
- 3. Aclidinium (Tudorza Pressair)
- 4. LAMA + LABA Combination Inhalers
- 5. Ipratropium (Atrovent) — Short-Acting Option for Emergencies
- How to Talk to Your Doctor About Alternatives
- Try to Find Yupelri Before Switching
Can't find Yupelri in stock? Learn about the best COPD alternatives to revefenacin, including other LAMAs and nebulized options, and how to talk to your doctor.
If you've been prescribed Yupelri (revefenacin) for COPD but can't find it at a pharmacy, knowing your alternatives can help prevent a dangerous gap in your treatment. Yupelri is a long-acting muscarinic antagonist (LAMA) delivered via nebulizer — and while it's unique in some ways, there are several other COPD medications that work through similar mechanisms. This guide covers your main alternatives and what to discuss with your doctor.
Important: Never stop or switch your COPD medication without consulting your prescriber first. COPD can worsen quickly if maintenance therapy is interrupted. The alternatives below are starting points for a conversation with your pulmonologist or PCP.
Why Is Yupelri Unique? (And Why Alternatives Aren't Always Identical)
Yupelri is the only once-daily LAMA specifically designed for nebulizer delivery in the US. It was developed for patients who cannot effectively use handheld inhaler devices — due to arthritis, cognitive limitations, coordination difficulties, or personal preference. If your doctor prescribed Yupelri for one of these reasons, any alternative should ideally maintain the nebulized delivery or address your specific challenge with traditional inhalers.
That said, there are several LAMAs and combination COPD medications available in inhaler form that may be clinically equivalent for patients who can manage them.
Other LAMA Medications (Same Drug Class as Yupelri)
Long-acting muscarinic antagonists (LAMAs) are the same class as Yupelri. They all work by blocking M3 muscarinic receptors in the airways to cause bronchodilation. Here are the main alternatives:
1. Tiotropium (Spiriva HandiHaler / Spiriva Respimat)
Tiotropium (Spiriva) is the most widely prescribed LAMA in the US and is often considered the gold standard for COPD maintenance. It's available as a dry powder inhaler (HandiHaler) and a soft mist inhaler (Respimat). Both forms are once daily, like Yupelri.
Cost: $400–$550/month brand-name; generics for Spiriva Respimat are available and significantly cheaper
Availability: Widely stocked at virtually all retail pharmacies
Note: Many insurers require documented failure of tiotropium before they will cover Yupelri
2. Umeclidinium (Incruse Ellipta)
Umeclidinium (Incruse Ellipta) is a once-daily LAMA delivered via the Ellipta dry powder inhaler. Generic umeclidinium is now available, making it one of the more affordable LAMA options. It has a well-established safety profile and similar efficacy to other LAMAs.
Cost: Generic available; significantly lower cost than Yupelri
Availability: Widely stocked at most pharmacies
3. Aclidinium (Tudorza Pressair)
Aclidinium (Tudorza Pressair) is a twice-daily LAMA inhaled via dry powder inhaler. While it requires twice-daily dosing (unlike Yupelri's once-daily regimen), it is a reasonable LAMA alternative for patients who can use a dry powder inhaler.
Note: Twice-daily dosing may be less convenient but can be beneficial for some patients who need more consistent 24-hour coverage
4. LAMA + LABA Combination Inhalers
If your COPD is moderate to severe and a single bronchodilator isn't providing adequate symptom control, your doctor may consider a LAMA+LABA combination. These combine a LAMA with a long-acting beta-agonist (LABA) for dual bronchodilation. Options include:
Anoro Ellipta (umeclidinium/vilanterol) — once-daily dry powder inhaler
Stiolto Respimat (tiotropium/olodaterol) — once-daily soft mist inhaler
Bevespi Aerosphere (glycopyrrolate/formoterol) — twice-daily metered-dose inhaler
5. Ipratropium (Atrovent) — Short-Acting Option for Emergencies
If you need a temporary bridge while locating your Yupelri supply, ipratropium (Atrovent) is a short-acting anticholinergic bronchodilator available as a nebulized solution or MDI inhaler. It works through the same anticholinergic mechanism as Yupelri but must be dosed 3–4 times daily and is not a long-term replacement. It is widely stocked and much less expensive. Discuss this option with your doctor if you're facing a gap in your Yupelri supply.
How to Talk to Your Doctor About Alternatives
When discussing alternatives with your doctor, be prepared to share:
Why you were originally prescribed Yupelri (inability to use inhaler, preference for nebulizer, prior medication failures)
Whether you can use handheld dry powder or pressurized inhaler devices
Your current COPD severity and symptom control
Your insurance coverage and what is on formulary
Try to Find Yupelri Before Switching
Before switching medications, exhaust your options for finding Yupelri in stock. medfinder.com can check pharmacies near you for stock without you having to call around. See our full guide: How to Find Yupelri in Stock Near You. Switching COPD medications can require re-authorization, adaptation, and sometimes re-training on a new device — so locating your current prescription is worth the effort first.
Frequently Asked Questions
Tiotropium (Spiriva Respimat or HandiHaler) is the most commonly prescribed alternative to Yupelri. Both are once-daily LAMAs with similar mechanisms of action and clinical efficacy. Spiriva is widely stocked at retail pharmacies and has generic options available at lower cost.
As of 2026, Yupelri (revefenacin) is the only once-daily nebulized LAMA approved for COPD maintenance in the US. Ipratropium (Atrovent) is available as a nebulized short-acting anticholinergic that can serve as a temporary bridge, but it must be dosed 3–4 times daily and is not a long-term substitute.
Yes, with your doctor's guidance. Tiotropium (Spiriva) works through the same LAMA mechanism as Yupelri and is typically considered clinically equivalent for most COPD patients. Your doctor will assess whether your inhaler technique is adequate for the Spiriva Respimat or HandiHaler device before recommending a switch.
There is no generic for Yupelri itself as of 2026. However, generic umeclidinium (generic for Incruse Ellipta) is available and significantly less expensive. Your doctor and pharmacist can help determine whether a generic LAMA is appropriate for your COPD management.
No — do not stop taking your COPD maintenance medication without talking to your doctor first. If you're running low on Yupelri, contact your prescriber immediately. They can provide guidance on temporary alternatives, emergency samples, or help locate a pharmacy that has it in stock.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Yupelri also looked for:
More about Yupelri
34,034 have already found their meds with Medfinder.
Start your search today.





